MedPath

BLES

BLES

Approved
DIN Number

02245464

Drug Class

Human

Market Date

Feb 5, 2002

Company
HC

bles biochemicals inc

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02245464
AIG Number0252489001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Ethical
A
ATC Code
R07AA02 NATURAL PHOSPHOLIPIDS
Product Specifications
Dosage FormSuspension
Route of AdministrationIntratracheal
AHFS Classification48:36.00
Health Canada Classification

ACTIVE INGREDIENTS (2)

PHOSPHOLIPIDActive
Strength: 27 MG / ML
Monograph: PHOSPHOLIPID
SURFACTANT-ASSOCIATED PROTEINS SP-B AND SP-CActive
Strength: 500 MCG / ML
Monograph: SURFACTANT-ASSOCIATED PROTEINS SP-B AND SP-C

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.